Vtv Therapeutics Inc. (VTVT) — 8-K Filings

8-K Filings (19)

• 8-K Filing — Dec 19, 2025
• vTv Therapeutics Files 8-K for Regulation FD Disclosure — Sep 10, 2025 Risk: low
  vTv Therapeutics Inc. filed an 8-K on September 10, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of
• vTv Therapeutics Files 8-K for Material Agreement — Sep 2, 2025 Risk: low
  On August 29, 2025, vTv Therapeutics Inc. filed an 8-K report detailing a material definitive agreement and financial statements. The company, incorporated in D
• vTv Therapeutics Schedules Shareholder Vote — Jun 12, 2025 Risk: medium
  On June 10, 2025, vTv Therapeutics Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not specify the
• vTv Therapeutics Files 8-K: Director/Officer Changes & Financials — May 19, 2025 Risk: low
  On May 19, 2025, vTv Therapeutics Inc. filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensator
• vTv Therapeutics Files 8-K for Routine Disclosures — May 16, 2025 Risk: low
  vTv Therapeutics Inc. filed an 8-K on May 16, 2025, primarily for a Regulation FD Disclosure and to file financial statements and exhibits. The filing does not
• vTv Therapeutics Announces Leadership and Compensation Changes — Apr 11, 2025 Risk: medium
  On April 11, 2025, vTv Therapeutics Inc. filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensat
• vTv Therapeutics Files 8-K for March 31, 2025 — Mar 31, 2025 Risk: low
  vTv Therapeutics Inc. filed an 8-K on March 31, 2025, reporting on financial statements and exhibits. The filing does not appear to contain any material new inf
• vTv Therapeutics Files 8-K — Mar 17, 2025 Risk: low
  vTv Therapeutics Inc. filed an 8-K on March 17, 2025, reporting on events that occurred on March 14, 2025. The filing is categorized under 'Other Events' and 'F
• vTv Therapeutics Reports Board and Officer Changes — Feb 27, 2025 Risk: medium
  vTv Therapeutics Inc. announced on February 24, 2025, a change in its board of directors. Specifically, the company reported the departure of certain officers a
• vTv Therapeutics Files 8-K Report — Jan 13, 2025 Risk: low
  On January 13, 2025, vTv Therapeutics Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial Statement
• vTv Therapeutics Terminates Material Agreement — Oct 25, 2024 Risk: medium
  vTv Therapeutics Inc. announced on October 22, 2024, the termination of a material definitive agreement. The company, incorporated in Delaware, filed this 8-K r
• vTv Therapeutics Files 8-K — Jul 26, 2024 Risk: low
  On July 26, 2024, vTv Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific n
• vTv Therapeutics Inc. Files 8-K for Material Definitive Agreement — Jul 2, 2024 Risk: medium
  On June 26, 2024, vTv Therapeutics Inc. entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement, its coun
• vTv Therapeutics Files 8-K on Shareholder Matters — Jun 14, 2024 Risk: low
  vTv Therapeutics Inc. filed an 8-K on June 14, 2024, reporting on matters submitted to a vote of security holders as of June 11, 2024. The filing details the co
• vTv Therapeutics to be Acquired by G42 Healthcare Investments — Mar 26, 2024 Risk: medium
  vTv Therapeutics Inc. announced on March 25, 2024, that it entered into a definitive agreement to be acquired by G42 Healthcare Investments Limited. The transac
• vTv Therapeutics Appoints New CEO & Chairman — Mar 14, 2024 Risk: medium
  vTv Therapeutics Inc. announced on March 13, 2024, a change in its board of directors. Specifically, Dr. Stephen L. Hoffman has been appointed as the new Chief
• vTv Therapeutics Files 8-K — Mar 5, 2024 Risk: low
  On March 5, 2024, vTv Therapeutics Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No sp
• vTv Therapeutics Strikes Deal with 03 Life Sciences, Leadership Changes — Feb 28, 2024 Risk: medium
  vTv Therapeutics Inc. (VTVT) entered into a material definitive agreement on February 23, 2024, with 03 Life Sciences. This agreement involves the departure of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX